Operating Income for Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's current operating income (TTM) is $11.00B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
GILD
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$11.00B
YoY change
+611.0%
5Y CAGR
+23.8%
Peak year (2015)
$22.19B
Cumulative operating income
$149.16B
Operating Income history chart for Gilead Sciences (GILD) from 1990 to 2025
Operating Income history table for Gilead Sciences (GILD) from 1990 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $11.82B | +611.0% | ||
| 2024 | $1.66B | -78.1% | ||
| 2023 | $7.61B | +3.8% | ||
| 2022 | $7.33B | -26.1% | ||
| 2021 | $9.92B | +143.6% | ||
| 2020 | $4.07B | -5.0% | ||
| 2019 | $4.29B | -47.7% | ||
| 2018 | $8.20B | -41.9% | ||
| 2017 | $14.12B | -19.9% | ||
| 2016 | $17.63B | -20.5% | ||
| 2015 | $22.19B | +45.4% | ||
| 2014 | $15.27B | +237.4% | ||
| 2013 | $4.52B | +12.8% | ||
| 2012 | $4.01B | +5.8% | ||
| 2011 | $3.79B | -4.4% | ||
| 2010 | $3.96B | +12.3% | ||
| 2009 | $3.53B | +31.8% | ||
| 2008 | $2.68B | +23.7% | ||
| 2007 | $2.16B | -385.3% | ||
| 2006 | -$758.75M | -168.4% | ||
| 2005 | $1.11B | +76.8% | ||
| 2004 | $627.39M | -495.4% | ||
| 2003 | -$158.68M | -295.9% | ||
| 2002 | $81.01M | -167.1% | ||
| 2001 | -$120.69M | +130.7% | ||
| 2000 | -$52.32M | +1.2% | ||
| 1999 | -$51.70M | -34.0% | ||
| 1998 | -$78.30M | +8.6% | ||
| 1997 | -$72.10M | +99.7% | ||
| 1996 | -$36.10M | +12.8% | ||
| 1995 | -$32.00M | -9.1% | ||
| 1994 | -$35.20M | — | ||
| 1992 | -$18.20M | +188.9% | ||
| 1991 | -$6.30M | +31.3% | ||
| 1990 | -$4.80M | — |
Operating Income values are taken from Gilead Sciences's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Gilead Sciences (GILD) operating income is $11.82B – surged 611.0% year-over-year.
Gilead Sciences operating income has recorded the values shown across consecutive periods, with a +23.8% compound annual growth rate over 2020–2025 (5 years).
Between 2015 and 2025, Gilead Sciences operating income plunged 46.8%, falling from $22.19B to $11.82B.
The highest annual operating income of $22.19B was reported in 2015. The lowest in the available history was -$758.75M in 2006.
Gilead Sciences (GILD) sits 8th of 8 Healthcare peers we track on this metric, against a peer median of $22.84B.
Gilead Sciences Operating Income by Year
Gilead Sciences Operating Income 2025: $11.82B
Gilead Sciences operating income in 2025 was $11.82B, surged 611.0% from 2024.
Gilead Sciences Operating Income 2024: $1.66B
Gilead Sciences operating income in 2024 was $1.66B, plunged 78.1% below 2023.
Gilead Sciences Operating Income 2023: $7.61B
Gilead Sciences operating income in 2023 was $7.61B, edged up 3.8% from 2022.
Gilead Sciences Operating Income 2022: $7.33B
Gilead Sciences operating income in 2022 was $7.33B, declined 26.1% below 2021.
Gilead Sciences Operating Income 2021: $9.92B
Gilead Sciences operating income in 2021 was $9.92B.
See more financial history for Gilead Sciences (GILD).
Sector peers — Operating Income
Companies in the same sector as Gilead Sciences, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is Gilead Sciences's operating income?
- Latest reported operating income for Gilead Sciences (GILD) is $11.00B (period ending December 31, 2025).
How has Gilead Sciences operating income changed year-over-year?
- Gilead Sciences (GILD) operating income changed +611.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Gilead Sciences operating income?
- Gilead Sciences (GILD) operating income compound annual growth rate is +23.8% over the most recent 5 years available.
When did Gilead Sciences operating income hit its highest annual value?
- Gilead Sciences operating income reached its highest annual value of $22.19B in 2015.
What was Gilead Sciences operating income in 2024?
- Gilead Sciences (GILD) operating income in 2024 was $1.66B.
What was Gilead Sciences operating income in 2025?
- Gilead Sciences (GILD) operating income in 2025 was $11.82B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
GILD Overview
Company profile, financial tools, and key metrics
GILD Revenue Counter
Earns $933.60 every second. See per minute, hour, and day.
GILD Earnings Counter
Earns $269.85 per second net profit. See per minute, hour, and day.
GILD Economic Scale
Exceeds Albania's GDP. Compare with world economies.
GILD What If Invested
What if you had invested $1,000? See historical returns from any date.
GILD How It Makes Money
Discover visual breakdown of $29.44B in revenue — where it comes from and where it goes.
GILD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
GILD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
GILD Daily Price Character
Explosive · 48.7% historical win rate (green days). Streaks & record days.
GILD Buybacks
1.26% TTM buyback yield. Shareholder yield & SBC comparison.
GILD Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
GILD Dividend Profile
Yield: 2.48%. Safety: 8/8. See full history.
GILD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
GILD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.